Ximaract

Ximaract is an intracameral antibiotic solution designed for ophthalmic use. It contains cefuroxime, a cephalosporin antibiotic, and is used to prevent infections after cataract surgery. This sterile solution ensures targeted delivery to the eye's anterior chamber.

Ximaract is primarily used to reduce the risk of bacterial endophthalmitis following cataract surgery. It works by targeting a broad spectrum of bacteria that may enter the eye during the procedure. The medication is administered directly into the eye to provide localized protection. It is not intended for systemic infections or other types of eye conditions.

When administered as directed, Ximaract helps prevent infection by inhibiting bacterial growth in the eye. Patients may experience temporary blurred vision or mild discomfort at the injection site. These effects are generally mild and resolve quickly. The solution is preservative-free to minimize irritation.

Ximaract should only be used by a healthcare professional experienced in intracameral injections. The solution must be inspected visually before use to ensure clarity and absence of particles. Patients with known allergies to cephalosporins or penicillin should inform their doctor. Proper aseptic technique is essential to avoid contamination.

No significant drug interactions have been reported with Ximaract due to its localized administration. However, patients using other eye medications should discuss their regimen with a healthcare provider. Combining Ximaract with systemic antibiotics may increase the risk of side effects. Always disclose all medications to your doctor before use.